SAB Biotherapeutics, Inc. (SABS): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0000919574-26-005263

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)